ERBB2 and breast carcinoma: Consistent with prior research56,57, we revealed that TNBC, particularly the MPS2 subtype, displays distinct RNA splicing patterns in comparison with luminal subtypes or HER2-enriched breast cancer, featuring more pronounced splicing dysregulation57,58.